John C. Ruckdeschel, MD

Ugo Pastorino, MD

Keunchil Park, MD, PhD

Dr. Benjamin Levy, MD

Keith Kerr, BSc, MB ChB, FRCPath, FRCPE

Roy S. Herbst, MD, PhD

Peter Hammerman, MD, PhD

FDA Corner - Interview with Amy Mckee, MD

PD-L1 Blueprint Project

Welcome to Year Two of the IASLC Lung Cancer News

Drug Development in the 21st Century

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A New Paradigm Post-IASLC WCLC 2016